February 2007

The AAWC and HVO Partner to Establish New Wound Care Programs

The Association for the Advancement of Wound Care (AAWC, Malvern, Pa) specializes in facilitating the highest quality treatment for those who suffer with wounds. The Health Volunteers Overseas (HVO), a private, nonprofit membership organization in cooperation with the AAWC, is striving to improve global health through education and have entered into a partnership to develop educational programs in the wound management field.
These programs will draw from the expertise of healthcare providers including nurses, physical therapists, physicians, podiatrists, dermatologists, and others. Multidisciplinary, team-based volunteer programs will be formulated and volunteer sites are being explored in both Asia and Latin America with future prospects in Africa.
This partnership will provide much needed infrastructure and support for the global arm of the AAWC’s World Wound Care Alliance (WWCA). The AAWC’s plans for a global wound care initiative and HVO’s ability to implement various clinical programs demonstrate efforts that will certainly be a success for the wound care field.
Visit http://www.aawcone.org or http://www.hvousa.org for more information.

Investor AB and Morgan Stanley Acquire Mölnlycke Health Care Group for $3.7 Billion

Investor AB (Stockholm, Sweden) and Morgan Stanley acquired Mölnlycke Health Care (Goteborg, Sweden) from Apax Partners for $3.7 billion.
Mölnlycke manufactures and sells wound care and surgical products primarily for the professional healthcare sector.
Lennart Johansson, head of Business Development at Investor AB said, “We are very enthusiastic about the acquisition and the opportunity to develop this leading healthcare company. Mölnlycke’s market-leading positions across a range of wound care and surgical products represent a strong platform for continued international growth, both organically as well as via acquisitions.”
Mölnlycke Chief Executive Officer John Samuel said, “This is a great outcome for all concerned. Apax has helped create a strong company poised for significant growth. Investor AB is a long-term partner committed to supporting our aspirations, and the management and employees are looking forward to an exciting future. We will continue the progress we have already made in creating a world-class medical products company.”
The acquisition is subject to approval from the relevant competition authorities.
Visit http://www.investorab.com for more information.

New Advanced Wound Care Directory for Healthcare Practitioners Launched

Supreme Medical Fulfillment Systems, Inc (Mobile, Ala) recently launched a new e-commerce website. This added benefit to Supreme Medical’s national customer base allows users to log-on to place orders, obtain pricing, and check the status of pending orders.
The website is the first of its kind, allowing healthcare professionals to view the full product catalog and published wholesale pricing without having to fill out tedious account registration forms. The site’s biggest asset is the largest and most comprehensive advanced wound care section. The wound care section allows users to browse product lines divided into more than 28 separate wound care dressing categories.
Visit http://www.suprememedical.com for more information.

Innocoll Receives FDA Approval to Commence Phase 2 Clinical Trial for Topical Treatment

Innocoll, Inc (Athlone, Ireland) announces that the US Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application to conduct a Phase 2 Study for CollaRx™ gentamicin as a topical antibiotic treatment for mildly infected diabetic foot ulcers.
CollaRx gentamicin is a biodegradable and fully resorbable gentamicin collagen sponge formulated and manufactured using Innocoll’s proprietary CollaRx technology. Upon application to wounds, the product releases gentamicin—a concentration-dependent aminoglycoside antibiotic used for local action.
Visit http://www.innocoll.com for more information.

RecoverCare and Sten-Barr Finalize Merger

RecoverCare (Plymouth Meeting, Pa) and Sten-Barr Medical (Tampa, Fla) have signed an agreement that will combine the companies. Both organizations offer therapeutic support surfaces, specialty beds, and bariatric equipment to hospitals, nursing homes, and home care patients. The deal was finalized in January 2007.
The merger will result in better service to both companies and existing customers. This growth initiative is a bold step to enhance the national leaders in specialty mattresses and beds.
Visit http://www.recovercare.com or http://www.stenbarr.com for more information.

Bayer Licenses Biodrug Delivery Technology for Wound Care

DelSiTech (Turku, Finland) signed a license agreement with Bayer Innovation, a subsidiary of Germany’s Bayer group, in a deal that could lead to the creation of a new generation of wound care products.
Bayer wants to use DelSiTech’s novel silica-based biodrug delivery technology in the wound care setting. Under the terms of the agreement, Bayer Innovation gets exclusive rights to use DelSiTech’s technology in wound application. In return, DelSiTech receives a signing fee, milestone payments, and royalties covering future sales of products using the technology.
With wound care being a critically important area with unmet medical need, Bayer and DelSiTech will undoubtedly find new applications for technology.
Visit http://www.delsitech.com/eng/news for more information.

Back to top
iuwerksdfgh